Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ricin vaccine - Soligenix

Next Previous
X
Search
Drug Profile

Ricin vaccine - Soligenix

Alternative Names: recombinant ricin toxin A-chain subunit - Soligenix; Ricin toxin vaccine - Soligenix; Ricin vaccine - DOR BioPharma; RiVax

Latest Information Update: 13 Mar 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Texas Southwestern Medical Center
  • Developer Soligenix
  • Class Subunit vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ricin poisoning
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Ricin poisoning

Most Recent Events

  • 09 Mar 2023 Ricin vaccine is still in phase-I trials for Ricin poisoning (Prevention) in USA (Soligenix pipeline, March 2023)
  • 28 Feb 2023 No recent reports of development identified for phase-I development in Ricin poisoning(Prevention) in USA (IM, Injection)
  • 04 Nov 2021 Pharmacodynamics data from preclinical studies in Ricin poisoning released by Soligenix

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top